MyFinsight
Home
Blog
About
Proceeds from issuance of
convertible notes, net of...
$672,435K
Proceeds from issuance of
common stock pursuant...
$13,368K
(-11.16%↓ Y/Y)
Net cash provided by
financing activities
$211,438K
(1305.18%↑ Y/Y)
Canceled cashflow
$474,365K
Net increase in
cash, cash...
$5,822K
(2.61%↑ Y/Y)
Canceled cashflow
$205,616K
Exchange and repurchase
of 2029...
$474,365K
Proceeds from maturities
of investments
$25,847K
(-39.18%↓ Y/Y)
Stock-based compensation
$30,573K
(-10.79%↓ Y/Y)
Change in fair value of
holdback liabilities
-$12,158K
Debt conversion
inducement expense
$11,678K
Depreciation and
amortization
$6,936K
(-42.72%↓ Y/Y)
Unrealized foreign
exchange loss (gain)
-$896K
(-170.55%↓ Y/Y)
Amortization of debt discount
and offering costs
$658K
(-23.49%↓ Y/Y)
Non-cash lease expense
$595K
(-27.97%↓ Y/Y)
Inventory
-$395K
(-107.89%↓ Y/Y)
Net cash used in
investing activities
-$159,991K
(-603.78%↓ Y/Y)
Net cash (used in)
provided by operating...
-$44,252K
(-539.05%↓ Y/Y)
Effect of exchange rate
on cash, cash...
-$1,373K
(-141.85%↓ Y/Y)
Canceled cashflow
$25,847K
Canceled cashflow
$63,889K
Purchase of investments
$160,815K
(147.17%↑ Y/Y)
Net loss
-$67,227K
(-227.33%↓ Y/Y)
Payments made for
additions to intangible...
$25,000K
Purchase of property and
equipment
$23K
(-86.23%↓ Y/Y)
Accounts payable,
accrued expenses and...
-$19,061K
(-185.42%↓ Y/Y)
Accounts receivable
$13,744K
(-46.94%↓ Y/Y)
Other assets
$5,835K
(334.80%↑ Y/Y)
Prepaid and other
current assets
$1,084K
(-84.76%↓ Y/Y)
Operating lease
liabilities
-$630K
(21.54%↑ Y/Y)
Other
$299K
(-55.64%↓ Y/Y)
Holdback liabilities
-$261K
Back
Back
Cash Flow
Mirum Pharmaceuticals, Inc. (MIRM)
Mirum Pharmaceuticals, Inc. (MIRM)
source: myfinsight.com